Ocular surface disease limits surgical options
As laser vision correction outcomes continue to improve, the occasional limiting factor for the patient’s success is the ocular surface.
Ocular surface disease (OSD) is a commonly diagnosed ocular condition in the general population. It is estimated that over 30 million people in the United States suffer to some extent from dry eye.1
As the U.S. population continues to age, the number of patients with dry eye also increases.
In 2016, OSD became the most common complication of laser vision correction.2 The incidence peaks at one week and up to 48 percent of patients still have some dry eye symptoms at three months.2
Also, dry eye symptoms and irritation associated with contact lens wear is one of the most common reasons why patients elect laser vision correction.3
This means diagnosing and treating dry eye in the management of refractive surgery patients and identifying those patients at risk prior to surgery is important. From history there are many factors that identify at risk patients.
OSD treatment, diagnostics continue to evolve
Female patients have an increased risk of dry eye in the general population and an increased risk of dry eye after laser-assisted in situ keratomileusis (LASIK) surgery.
Research found females to be 32 percent more likely to have dry eye symptoms after surgery. Hyperopes are also more likely to have dry eye symptoms.